439 related articles for article (PubMed ID: 12478229)
1. Pathophysiology of coronary artery restenosis.
Schwartz RS; Henry TD
Rev Cardiovasc Med; 2002; 3 Suppl 5():S4-9. PubMed ID: 12478229
[TBL] [Abstract][Full Text] [Related]
2. The vessel wall reaction in restenosis.
Schwartz RS
Semin Interv Cardiol; 1997 Jun; 2(2):83-8. PubMed ID: 9546996
[TBL] [Abstract][Full Text] [Related]
3. Preclinical restenosis models: challenges and successes.
Touchard AG; Schwartz RS
Toxicol Pathol; 2006; 34(1):11-8. PubMed ID: 16507539
[TBL] [Abstract][Full Text] [Related]
4. Mechanisms of late lumen loss after antiproliferative percutaneous coronary intervention using beta-irradiation in a porcine model of restenosis.
Deiner C; Loddenkemper C; Rauch U; Rosenthal P; Pauschinger M; Schwimmbeck PL; Schultheiss HP; Pels K
Cardiovasc Revasc Med; 2007; 8(2):94-8. PubMed ID: 17574167
[TBL] [Abstract][Full Text] [Related]
5. [Expression of intercellular adhesion molecule-1 and vascular cell adhesion molecule-1 in the pig coronary artery injury model: comparison of plain old balloon angioplasty and stent implantation].
Shimizu N; Suzuki H; Wakabayashi K; Iso Y; Shibata M; Yorozuya M; Katagiri T; Takeyama Y
J Cardiol; 2004 Mar; 43(3):131-9. PubMed ID: 15067801
[TBL] [Abstract][Full Text] [Related]
6. Preclinical restenosis models and drug-eluting stents: still important, still much to learn.
Schwartz RS; Chronos NA; Virmani R
J Am Coll Cardiol; 2004 Oct; 44(7):1373-85. PubMed ID: 15464316
[TBL] [Abstract][Full Text] [Related]
7. Incomplete neointimal coverage of sirolimus-eluting stents: angioscopic findings.
Kotani J; Awata M; Nanto S; Uematsu M; Oshima F; Minamiguchi H; Mintz GS; Nagata S
J Am Coll Cardiol; 2006 May; 47(10):2108-11. PubMed ID: 16697331
[TBL] [Abstract][Full Text] [Related]
8. Restenosis is not associated with stent length in a pig model of coronary stent implantation.
Koutouzis M; Papalois A; Kyrzopoulos S; Dafnomili P; Kyriakides ZS
Cardiol J; 2008; 15(5):458-62. PubMed ID: 18810722
[TBL] [Abstract][Full Text] [Related]
9. Intracoronary brachytherapy for the prevention of restenosis after percutaneous coronary revascularization.
Sheppard R; Eisenberg MJ; Donath D; Meerkin D
Am Heart J; 2003 Nov; 146(5):775-86. PubMed ID: 14597925
[TBL] [Abstract][Full Text] [Related]
10. Restenosis following implantation of bare metal coronary stents: pathophysiology and pathways involved in the vascular response to injury.
Scott NA
Adv Drug Deliv Rev; 2006 Jun; 58(3):358-76. PubMed ID: 16733073
[TBL] [Abstract][Full Text] [Related]
11. Polymer stent coating for prevention of neointimal hyperplasia.
Billinger M; Buddeberg F; Hubbell JA; Elbert DL; Schaffner T; Mettler D; Windecker S; Meier B; Hess OM
J Invasive Cardiol; 2006 Sep; 18(9):423-6; discussion 427. PubMed ID: 16954581
[TBL] [Abstract][Full Text] [Related]
12. Paclitaxel-eluting balloon: from bench to bed.
De Labriolle A; Pakala R; Bonello L; Lemesle G; Scheinowitz M; Waksman R
Catheter Cardiovasc Interv; 2009 Apr; 73(5):643-52. PubMed ID: 19309715
[TBL] [Abstract][Full Text] [Related]
13. Use of a tacrolimus-eluting stent to inhibit neointimal hyperplasia in a porcine coronary model.
Huang Y; Salu K; Wang L; Liu X; Li S; Lorenz G; Wnendt S; Verbeken E; Bosmans J; Van de Werf F; De Scheerder I
J Invasive Cardiol; 2005 Mar; 17(3):142-8. PubMed ID: 15867441
[TBL] [Abstract][Full Text] [Related]
14. Intravascular brachytherapy: a review of the current vascular biology.
Apisarnthanarax S; Chougule P
Am J Clin Oncol; 2003 Jun; 26(3):e13-21. PubMed ID: 12796611
[TBL] [Abstract][Full Text] [Related]
15. Local methylprednisolone delivery using a BiodivYsio phosphorylcholine-coated drug-delivery stent reduces inflammation and neointimal hyperplasia in a porcine coronary stent model.
Huang Y; Liu X; Wang L; Verbeken E; Li S; De Scheerder I
Int J Cardiovasc Intervent; 2003; 5(3):166-71. PubMed ID: 12959735
[TBL] [Abstract][Full Text] [Related]
16. Inhibition of neointima formation by a novel drug-eluting stent system that allows for dose-adjustable, multiple, and on-site stent coating.
Wessely R; Hausleiter J; Michaelis C; Jaschke B; Vogeser M; Milz S; Behnisch B; Schratzenstaller T; Renke-Gluszko M; Stöver M; Wintermantel E; Kastrati A; Schömig A
Arterioscler Thromb Vasc Biol; 2005 Apr; 25(4):748-53. PubMed ID: 15681298
[TBL] [Abstract][Full Text] [Related]
17. Relationship between neointimal coverage of sirolimus-eluting stents and lesion characteristics: a study with serial coronary angioscopy.
Yamamoto M; Okamatsu K; Inami S; Takano M; Yokoyama S; Ohba T; Ibuki C; Hata N; Seino Y; Mizuno K
Am Heart J; 2009 Jul; 158(1):99-104. PubMed ID: 19540398
[TBL] [Abstract][Full Text] [Related]
18. Particle debris from a nanoporous stent coating obscures potential antiproliferative effects of tacrolimus-eluting stents in a porcine model of restenosis.
Kollum M; Farb A; Schreiber R; Terfera K; Arab A; Geist A; Haberstroh J; Wnendt S; Virmani R; Hehrlein C
Catheter Cardiovasc Interv; 2005 Jan; 64(1):85-90. PubMed ID: 15619311
[TBL] [Abstract][Full Text] [Related]
19. Novel approaches to reduce restenosis.
Beyar R
Ann N Y Acad Sci; 2004 May; 1015():367-78. PubMed ID: 15201175
[TBL] [Abstract][Full Text] [Related]
20. Comparative healing response after sirolimus- and paclitaxel-eluting stent implantation in a pig model of restenosis.
Silva GV; Fernandes MR; Madonna R; Clubb F; Oliveira E; Jimenez-Quevedo P; Branco R; Lopez J; Angeli FS; Sanz-Ruiz R; Vaughn WK; Zheng Y; Baimbridge F; Canales J; Cardoso CO; Assad JA; Falotico R; Perin EC
Catheter Cardiovasc Interv; 2009 May; 73(6):801-8. PubMed ID: 19309735
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]